Drugs & Targets Myriad, Pfizer announce commercialization plan for talazoparib companion diagnostic October 12, 2018Vol.44 No.38
Drugs & Targets Foundation Medicine introduces liquid biopsy for solid tumors in patients with advanced cancer October 12, 2018Vol.44 No.38
Drugs & Targets Celyad announces agreement for Horizon Discovery’s shRNA platform to develop next- gen allogeneic CAR-T therapies October 12, 2018Vol.44 No.38
Drugs & Targets Novitas Solutions approves coverage of UPMC-developed test for diagnosis of thyroid nodules October 12, 2018Vol.44 No.38
Drugs & Targets FDA approves Kyprolis with dexamethasone for relapsed or refractory multiple myeloma October 05, 2018Vol.44 No.37
Drugs & Targets FDA authorizes first next-gen sequencing-based test in patients with ALL, MM October 05, 2018Vol.44 No.37
Drugs & Targets FDA approves Libtayo as first and only treatment for advanced CSCC October 05, 2018Vol.44 No.37
